Leerink Partners Reiterates Outperform Rating on Cardinal Health (CAH): "company is set up for solid FY2H'26 growth"
March 9, 2026 1:22 PM
Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $275.00 price target on Cardinal Health (NYSE: CAH)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
